Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Institute of HIV Research and Innovation, Bangkok, Thailand.
AIDS Res Ther. 2022 Dec 31;19(1):69. doi: 10.1186/s12981-022-00493-w.
Incident syphilis leads to changes in plasma HIV-1 RNA and CD4 + T-cell level in people with HIV (PWH) with viraemia. Its effect in PWH on suppressive antiretroviral therapy (ART) is less clear.
PWH on suppressive ART (plasma HIV-1 RNA < 50copies/mL) followed at the Queen Elizabeth Hospital, Hong Kong, China were regularly screened for syphilis. Their plasma HIV-1 RNA, CD4 + and CD8 + T-cell, and total lymphocyte levels before syphilis, during syphilis, and after successful treatment were compared.
Between 2005 and 2020, 288 syphilis episodes from 180 individuals were identified; 287 episodes were related to male, with a median age of 41 at diagnosis; 221 (77%) were syphilis re-infection. The rates of plasma HIV-1 suppression were statistically unchanged across the time-points (97% pre-syphilis, 98% during syphilis, and 99% post-treatment). Total lymphocyte, CD4+ and CD8+ T-cell levels decreased during incident syphilis (p<0.01), and rebounded post-treatment (p<0.01). VDRL titre was associated with declines in CD4+ T-cell (p=0.045), CD8+ T-cell (p=0.004), and total lymphocyte levels (p=0.021). Pre-syphilis CD4/CD8 ratio was associated with increases in CD8+ T-cell (p=0.001) and total lymphocyte levels (p=0.046) during syphilis. Syphilis re-infection was associated with an increase in total lymphocyte level (p=0.037). In the multivariable analysis, only pre-syphilis CD4/CD8 ratio was independently associated with increases in CD8+ T-cell (p=0.014) and total lymphocyte levels (p=0.039) during syphilis.
Among virally-suppressed PWH, total lymphocyte, CD4+, and CD8+ T-cell levels declined during incident syphilis but rebounded post-treatment. The status of plasma HIV suppression was unaffected by syphilis.
梅毒感染可导致 HIV 感染者(HIV+)的血浆 HIV-1 RNA 和 CD4+T 细胞水平发生变化。其对接受抑制性抗逆转录病毒治疗(ART)的 HIV+患者的影响尚不清楚。
在中国香港伊丽莎白女王医院接受抑制性 ART(血浆 HIV-1 RNA<50 拷贝/毫升)的 HIV+患者定期筛查梅毒。比较他们在梅毒感染前、感染期间和成功治疗后的血浆 HIV-1 RNA、CD4+和 CD8+T 细胞及总淋巴细胞水平。
2005 年至 2020 年间,从 180 名患者中共发现 288 例梅毒感染,287 例与男性有关,诊断时的中位年龄为 41 岁,221 例(77%)为梅毒再感染。在各个时间点,血浆 HIV-1 抑制率均无统计学差异(感染前为 97%,感染期间为 98%,治疗后为 99%)。总淋巴细胞、CD4+和 CD8+T 细胞水平在梅毒感染期间下降(p<0.01),治疗后回升(p<0.01)。VDRL 滴度与 CD4+T 细胞(p=0.045)、CD8+T 细胞(p=0.004)和总淋巴细胞水平(p=0.021)下降相关。梅毒感染前 CD4/CD8 比值与梅毒感染期间 CD8+T 细胞(p=0.001)和总淋巴细胞水平(p=0.046)的升高相关。梅毒再感染与总淋巴细胞水平升高相关(p=0.037)。多变量分析显示,仅梅毒感染前 CD4/CD8 比值与梅毒感染期间 CD8+T 细胞(p=0.014)和总淋巴细胞水平(p=0.039)的升高相关。
在病毒抑制的 HIV+患者中,总淋巴细胞、CD4+和 CD8+T 细胞水平在梅毒感染期间下降,但治疗后回升。梅毒感染对 HIV 抑制状态无影响。